This study will analyze survival and outcome of patients with severe haemophilia who undergo liver transplantation in Spain
- Patients with haemophilia who underwent liver transplantation and who have been
followed-up at any site in Spain.
- Patients without informed consent form.
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
| Descriptive Information | ||||
|---|---|---|---|---|
| Brief Title | Study Evaluating Liver Transplantation in Haemophilia Patients in Spain | |||
| Official Title | Liver Transplantation in Haemophilia Patients in Spain | |||
| Brief Summary | This study will analyze survival and outcome of patients with severe haemophilia who undergo liver transplantation in Spain | |||
| Detailed Description | Probability Sample | |||
| Study Type | Observational | |||
| Study Design | Observational Model: Cohort Time Perspective: Cross-Sectional | |||
| Target Follow-Up Duration | Not Provided | |||
| Biospecimen | Not Provided | |||
| Sampling Method | Probability Sample | |||
| Study Population | Patients with haemophilia who underwent liver transplantation and who have been followed-up at any site in Spain. | |||
| Condition |
| |||
| Intervention | Other: Epidemiological Non interventional Epidemiological Non interventional | |||
| Study Groups/Cohorts | Patients with haemophilia who undergo liver transplantation Patients with haemophilia who underwent liver transplantation and who have been followed up at any site in Spain. Intervention: Other: Epidemiological Non interventional | |||
| Publications * | Not Provided | |||
| * Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
| Recruitment Information | ||||
| Recruitment Status | Completed | |||
| Actual Enrollment | 11 | |||
| Original Estimated Enrollment | 10 | |||
| Actual Study Completion Date | June 2010 | |||
| Actual Primary Completion Date | June 2010 (Final data collection date for primary outcome measure) | |||
| Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
| |||
| Sex/Gender |
| |||
| Ages | Child, Adult, Older Adult | |||
| Accepts Healthy Volunteers | No | |||
| Contacts | Contact information is only displayed when the study is recruiting subjects | |||
| Listed Location Countries | Not Provided | |||
| Removed Location Countries | Spain | |||
| Administrative Information | ||||
| NCT Number | NCT00927992 | |||
| Other Study ID Numbers | B1831011 3082B1-4436 ( Other Identifier: Wyeth ) | |||
| Has Data Monitoring Committee | No | |||
| U.S. FDA-regulated Product | Not Provided | |||
| IPD Sharing Statement | Not Provided | |||
| Responsible Party | Wyeth is now a wholly owned subsidiary of Pfizer | |||
| Study Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer | |||
| Collaborators | Not Provided | |||
| Investigators |
| |||
| PRS Account | Wyeth is now a wholly owned subsidiary of Pfizer | |||
| Verification Date | December 2012 | |||
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
